Rxprim SRL
The score of Rxprim shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +43 % Total assets +45 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rxprim's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
Rxprim's financial analysis
- Solvency54.3%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rxprim
Rxprim's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.823.605
- VAT number
- BE0798823605
- Peppol
- Not found on Peppol as of 09 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 24 Feb 2023
- Registered office
- 5640 Mettet
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Rxprim (SRL) has been based in Mettet since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 94,384 € and equity of 241,373 €; its revenue is not published. Its solvency stands at 54.3%, below the median of its sector (65.0%).
Companies similar to Rxprim
Companies in the same business, of comparable size and area, outside its group.
- Elite Rent Computer consultancy and computer facilities management activities Overijse · balance sheet 444,267 €
- 06 Baronomie Woluwe-Saint-Lambert · balance sheet 444,489 €
- Mats Vastgoed Hoeilaart · balance sheet 444,174 €
- Immobilière 243 Auderghem · balance sheet 444,733 €
- Mapibalo Tubize · balance sheet 444,802 €
Frequently asked questions about Rxprim
What is the revenue of Rxprim?
Rxprim files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rxprim?
In Belgium, the VAT number is the company number prefixed with BE: BE0798823605 for Rxprim, if the company is VAT-registered. Its company number (CBE) is 0798.823.605.
Where is the registered office of Rxprim?
According to the CBE register, the registered office of Rxprim is in 5640 Mettet.
What is the equity of Rxprim?
At the close of the 2025 financial year, the equity of Rxprim amounts to 241,373 €, a solvency of 54.3% of total assets.
Who manages Rxprim?
The register lists 1 active mandates at Rxprim. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rxprim
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →